Haemophagocytic lymphohistiocytosis post-ChAdOx1 nCoV-19 vaccine: A rare case
The severe acute respiratory syndrome coronavirus 2 pandemic started in December 2019, spread like wildfire and took an immense toll on human life. ChAdOx1 nCoV-19 vaccine was used worldwide for the prevention of Covid-19. Covid-19 has been implicated in the causation of severe haemophagocytic lymph...
Saved in:
Published in | The National medical journal of India Vol. 37; no. 2; pp. 90 - 92 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
India
01.03.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The severe acute respiratory syndrome coronavirus 2 pandemic started in December 2019, spread like wildfire and took an immense toll on human life. ChAdOx1 nCoV-19 vaccine was used worldwide for the prevention of Covid-19. Covid-19 has been implicated in the causation of severe haemophagocytic lymphohistiocytosis (HLH) syndrome. However, the same has not been reported with ChAdOx1 nCoV-19 vaccine in the literature. We report a young man who developed secondary HLH post-ChAdOx1 nCoV-19 vaccination. |
---|---|
Bibliography: | ObjectType-Case Study-2 SourceType-Scholarly Journals-1 ObjectType-Feature-4 content type line 23 ObjectType-Report-1 ObjectType-Article-3 |
ISSN: | 0970-258X 2583-150X 2583-150X |
DOI: | 10.25259/NMJI_MS_466_21 |